Andrew Heim

924 total citations
10 papers, 20 citations indexed

About

Andrew Heim is a scholar working on Neurology, Genetics and Epidemiology. According to data from OpenAlex, Andrew Heim has authored 10 papers receiving a total of 20 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 2 papers in Genetics and 2 papers in Epidemiology. Recurrent topics in Andrew Heim's work include Myasthenia Gravis and Thymoma (4 papers), Peripheral Neuropathies and Disorders (3 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). Andrew Heim is often cited by papers focused on Myasthenia Gravis and Thymoma (4 papers), Peripheral Neuropathies and Disorders (3 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). Andrew Heim collaborates with scholars based in United States and Canada. Andrew Heim's co-authors include Mazen M. Dimachkie, Jon Frederick, Richard J. Barohn, Jeffrey Statland, Todd Levine, Mamatha Pasnoor, Laura Herbelin, Richard J. Barohn, Gary W. Gallagher and Sharon Nations and has published in prestigious journals such as Neurology, European Journal of Neurology and LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas).

In The Last Decade

Andrew Heim

8 papers receiving 20 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Heim United States	4	7	7	3	3	2	10	20
Nazanin Mirza‐Schreiber Germany	3	5 0.7×	3 0.4×	2 0.7×	4 1.3×		3	24
Raimonds Reščenko Latvia	2	13 1.9×	3 0.4×		3 1.0×		2	20
Corey Adams Canada	2	3 0.4×	4 0.6×		3 1.0×		2	8
Margarita M. Gerasimova Russia	1	3 0.4×	5 0.7×		3 1.0×		3	8
Neil R. Robertson United Kingdom	2	4 0.6×	2 0.3×	2 0.7×	3 1.0×		4	10
Andrea Fernandes United States	2	4 0.6×	6 0.9×	2 0.7×			4	21
Carmen Marciano Italy	2	4 0.6×	5 0.7×	1 0.3×	1 0.3×	1 0.5×	2	14
Sarah Louise Murphy Norway	2	5 0.7×	3 0.4×			3 1.5×	4	14
Haifeng Li China	2	2 0.3×	8 1.1×		2 0.7×		2	16
Gemma Olivé-Cirera Spain	4	3 0.4×	20 2.9×	1 0.3×	6 2.0×	3 1.5×	6	26

Countries citing papers authored by Andrew Heim

Since Specialization

Citations

This map shows the geographic impact of Andrew Heim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Heim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Heim more than expected).

Fields of papers citing papers by Andrew Heim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Heim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Heim. The network helps show where Andrew Heim may publish in the future.

Co-authorship network of co-authors of Andrew Heim

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Heim. A scholar is included among the top collaborators of Andrew Heim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Heim. Andrew Heim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Pasnoor, Mamatha, Vera Bril, Todd Levine, et al.. (2023). Phase 2 trial in acetylcholine receptor antibody‐positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study. European Journal of Neurology. 30(5). 1417–1424. 2 indexed citations

2.

Bhai, Salman, Robert Bowser, Suzan A. Moser, et al.. (2023). A 40-week Phase 2B Randomized, Multicenter, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Memantine in Amyotrophic Lateral Sclerosis (P8-8.011). Neurology. 100(17_supplement_2). 1 indexed citations

3.

Herbelin, Laura, et al.. (2021). A Patient Activities of Daily Living Scale for Amyotrophic Lateral Sclerosis. 2(1). 1 indexed citations

4.

Dimachkie, Mazen M., Pedro Machado, Thomas Blaettler, et al.. (2021). The Early History of Arimoclomol for Inclusion Body Myositis. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 2(2). 1 indexed citations

5.

Pasnoor, Mamatha, Andrew Heim, Laura Herbelin, et al.. (2020). Methotrexate Polyglutamation in a Myasthenia Gravis Clinical Trial. Kansas Journal of Medicine. 13(Suppl 2). 10–13. 3 indexed citations

6.

Heim, Andrew, Mazen M. Dimachkie, Mamatha Pasnoor, et al.. (2020). Amyloid Myopathy as an Inclusion Body Myositis Mimic. 1(4). 28–32. 4 indexed citations

7.

Dimachkie, Mazen M., Jeffrey Statland, Richard J. Barohn, et al.. (2020). CIDP Diagnostic Criteria and Response to Treatment. 1(2). 7–10.

8.

Jawdat, Omar, Duaa Jabari, Jeffrey Statland, Andrew Heim, & Richard J. Barohn. (2020). Clinical Findings in Isolated Bulbar Amyotrophic Lateral Sclerosis. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 1(4). 11–13.

9.

Dimachkie, Mazen M., Vera Bril, Todd Levine, et al.. (2019). Subcutaneous Immunoglobulin in Myasthenia Gravis: Results of a North American Open Label Study (N4.002). Neurology. 92(15_supplement). 5 indexed citations

10.

Frederick, Jon, et al.. (2019). Self-Prompted Discrimination and Operant Control of EEG Alpha. 6(2). 81–92. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact